Industry Reports
The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
The ultimate guide to the complex web of interactions within the U.S. prescription distribution and reimbursement system more >
The 2025-26 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
The most comprehensive tool for analyzing the economic and business realities of the U.S. pharmaceutical distribution industry. more >
From The Drug Channels Blog
Tuesday, July 14, 2026
Medicare Embraces Site-Neutral Payments. Why Haven't Employers?
By Bryce Platt, PharmD Provider-administered drugs are one of the fastest-growing and least-managed cost drivers for commercial plan sponsors. Despite that, recent data from more >
Friday, July 10, 2026
When Access Tightens, Prior Authorization Execution Becomes the Differentiator
Today's guest post comes from Megan Wetzel, Vice President of Product, Access and Affordability at CoverMyMeds. Megan examines how prior authorization execution has become a strategic differentiator for biopharma more >
